INNT
TOTAL INVALIDATION PROCESSED BY THE IB
08/31/2024
Back to search
Official data from USPTO
FURESTEM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/31/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
09/29/2016
Registration date
05/16/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2023
Last transaction
12/01/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Gwanak-gu, KR
Examiner
HAYES, GINA
Law office
L30
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Kangstem Biotech CO., LTD.
Representatives
KIM, HEE SO
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for medical purposes; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; cord blood; bouillons for stem cell cultures; stem cell medicine; pharmaceutical preparations for immunity adjustment; allergy medications; lotions for pharmaceutical purposes; medicament formulating agents; pharmaceutical agents for epidermis; microorganism preparation for medical and veterinary use; bacterial preparations for medical and veterinary use; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the treatment of cellsnot for cancer or chemo therapy; chemico-pharmaceutical preparationsnot for cancer or chemo therapy; reagents for medical usenot for cancer or chemo therapy; drugs for medical purposesnot for cancer or chemo therapy
Publications
History of USPTO decisions and trademark events.
26 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/10/2024
INPC
INVALIDATION PROCESSED
08/10/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/02/2024
C71T
CANCELLED SECTION 71
12/01/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/07/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/14/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/24/2017
FIMP
FINAL DISPOSITION PROCESSED
06/24/2017
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
06/15/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2017
CHPB
POST PUBLICATION AMENDMENT - ENTERED
04/03/2017
APET
ASSIGNED TO PETITION STAFF
04/03/2017
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/23/2017
GPNX
NOTIFICATION PROCESSED BY IB
03/11/2017
PUBO
PUBLISHED FOR OPPOSITION
02/28/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/22/2017
NPUB
NOTICE OF PUBLICATION
02/08/2017
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
01/24/2017
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2017
MAFR
APPLICATION FILING RECEIPT MAILED
01/10/2017
DOCK
ASSIGNED TO EXAMINER
01/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/05/2017
Continuous trademark protection
Get notified about every new filing that threatens FURESTEM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.